FENNEC PHARMACEUTICALS INC. (FENC) Operating cash flow 2016–2025
FENNEC PHARMACEUTICALS INC. (FENC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.5MFY2025 · since FY2016: -$2.1M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | -146.2% |
| FY2024 | $27.0M | +257.4% |
| FY2023 | -$17.1M | +5.1% |
| FY2022 | -$18.1M | -27.0% |
| FY2021 | -$14.2M | +8.8% |
| FY2020 | -$15.6M | -72.1% |
| FY2019 | -$9.1M | -15.8% |
| FY2018 | -$7.8M | -114.9% |
| FY2017 | -$3.6M | -71.4% |
| FY2016 | -$2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FENC financial trends
FENC RevenueFENC Net incomeFENC Net marginFENC Gross profitFENC Gross marginFENC Operating incomeFENC Operating marginFENC Free cash flowFENC Capital expendituresFENC Return on equityFENC Stock buybacksFENC Dividends paidFENC Total assetsFENC Total liabilitiesFENC Shareholders’ equityFENC overview →